Please Wait...

Clinical Trial Abstracts and Posters

Abstracts and Proceedings

2017

Emeric Chassaing, BS1, Philippe Vergnaud, MSc1, Tanja Schubert, PhD1, Hugo Marcel Vanderstichele, PhD2, Erik Stoops, Eng2 and Mélanie Bodnar-Wachtel, PhD1, (1)Bioclinica Lab, Lyon, France, (2)ADx NeuroSciences, Gent, Belgium.  Analytical Performance Characteristics of a Prototype Immunoassay for Quantification of Alpha-Synuclein in Human Cerebrospinal Fluid. AAIC 2017.

L. Bracoud, J. Fiebach, D. Purcell, E. Gaensler, A. Gass, C. Lindan, J. Barakos and J. Suhy. Validation of a simple severity scale for assessing ARIA-E. AAIC 2017.

E.Chassaing, M.Bodnar-Wachtel, T.Schubert, H.Vanderstichele, E.Stoops, and P.Vergnaud.  Analytical Performance Characteristics of a Novel Immunoassay for Quantification of Neurogranin Truncp75 in Human Cerebrospinal Fluid.  AD PD 2017

Emeric Chassaing, BS1, Mélanie Bodnar-Wachtel, PhD1, Tanja Schubert, PhD1, Hugo Marcel Vanderstichele, PhD2, Erik Stoops, Eng2 and Philippe Vergnaud, MSc1, (1)Bioclinica Lab, Lyon, France, (2)ADx NeuroSciences, Gent, Belgium.  Analytical Performance Characteristics of a Novel Immunoassay for the Quantification of BACE-1 in Human Cerebrospinal Fluid.  AAIC 2017

2016

Tiffini Voss, MD; Ying Zhang, PhD; Cyrille Sur, PhD; James Kost, PhD; Yi Mo, PhD; Joyce Suhy, PhD; Gregory Klein, PhD; Jerome Barakos, MD; Teresia Möller, PhD; Benjamin Newton, PhD; Lyn Harper Mozley, PhD; Julie Chandler, PhD; Yuki Mukai, MD; Christopher Randolph, PhD, ABPP-CN6; and Michael Egan, MD. Does Regional Amyloid Burden Impact Domain-Specific Cognitive Impairment?. AAIC 2016.

Joel Schaerer, Mehul Sampat, Florent Roche, Joonmi Oh, Luc Bracoud, Joyce Suhy and the Alzheimer's Disease Neuroimaging Initiative. Assessing Regional Cortical Thickness for Predicting MCI Conversion to AD. AAIC 2016.

Cyrille Sur, Yi Mo, James Kost, Tiffini Voss, Joyce Suhy, Luc Bracoud, Joonmi Oh, David Michelson, Michael Egan. Relationship between Volumetric MRI parameters, APOE4 and MMSE Status at baseline in Verubecestat (MK-8931) Mild-to-Moderate Alzheimer's Disease Phase 2/3 Trial. AAIC 2016.

Gregory Klein, Joël Schaerer, Florent Roche, Mehul Sampat, Gennan Chen, Joyce Suhy Bioclinica, Newark, CA, USA; Bioclinica, Lyon, France.  Effects of Partial Volume Differences Between Time points on Longitudinal Amyloid SUVR Measurements.  CTAD 2016

Gregory Klein, Mehul Sampat, Davis Staewen, David Scott, Joyce Suhy, Eric M Reiman, Kewei Chen. Head-to-Head Comparison of Image Analysis Methods in Longitudinal Alzheimer's Disease FDG Pet Studies. AAIC 2016.

C. Leurent, J. Goodman, E. Pickering, P. He, S. Duvvuri, E. Martucci, S. Kellogg, D. Purcell, J. Barakos, G. Klein, JW Kupiec, R. Alexander. Low Prevalence Of Amyloid Positivity In Healthy Elderly Participants Of A Methodology Study Evaluating Remote Tablet-based Cognitive Learning. AAIC 2016.

2015

Bracoud L, Bouguen E, Bonneville F, Schaerer J, Kiyasova V, Roche F, Basselerie H, Schneble HM, Oh J, Pueyo M, Suhy J, Vellas B, 1 BioClinica, Lyon, France and Newark, CA, USA, 2 Institut de Recherches Internationales Servier, Suresnes, France   3 CHU Toulouse, France. DWI and DTI results on the normal controls, MCI and AD Subjects from the ROSAS study. AAIC 2015.

Yu, H.J., Tan, C., Yan, Z., Miller C.G., Fuerst T., Engelke K., Metaxas, D., BioClinica, Inc., Princeton NJ and Germany Alacrita LLC, Cambridge MA,  Rutgers University, Piscataway NJ. Gender and age-related changes of thigh muscle fat infiltration in subjects of the OAI MRI cohort without radiographic osteoarthritis. ICFSR 2015.

Klein G, Sampat M, Staewen D, Suhy J, Bullich S, De Santi S, 1 BioClinica, Newark, CA, USA,  2 Piramal Imaging GmbH, Berlin, Germany 3 Piramal, Boston, MA. A study of optimal SUVR cutpoints and reference regions for Florbetaben PET. AAIC 2015.

Miller, C.G. PhD, Roemer, F.W. MD, Hoover, K.B. MD, PhD, Yu, H.J. PhD, Guermazi, A. MD, PhD, BioClinica, Inc., Newtown, PA, Alacrita LLC, Cambridge, MA, Department of Radiology, Boston University, Boston, MA, Department of Radiology, University of Erlangen-Nuremberg, Erlangen, Germany, Department of Radiology, VCU Health Systems, Richmond, VA. The Current Status of Imaging in Anti-NGF Clinical Trials. OARSI 2015.

Gregory Klein, Mehul Sampat, Davis Staewen, David Scott, Joyce Suhy BioClinica Inc, Newark, CA, USA. Comparison of SUVR Methods and Reference Regions in Amyloid PET. SNMMI 2015.

Klein G, Sampat M, Staewen D, Scott D, Suhy J, BioClinica, Newark, CA, USA. Effect size and spatial smoothing of ADNI Florbetapir and FDG PET. AAIC 2015.

Vergnaud P, Pagnon A, Bertholon C, Lhoste Y, Chassaing E, Borel O, Gineyts E, Schubert T, Clezardin P, Chapurlat R, Rousseau JCh.  Development of two polyclonal antibodies against the human periostin (PN) and analysis of their specificities in serum by Western blot (WB) and in bone by immunohistochemistry (IHC).  ASBMR 2015

Vergnaud P, Pagnon-Minot A, Bertholon C, Lhoste Y, Chassaing E, Borel O, Gineyts E, Schubert T, Clézardin P, Chapurlat R, Rousseau JCh, Bioclinica LAB, Lyon, France; Novotec, Lyon, France; INSERM Unit 1033 and University of Lyon, Lyon, France; Hospices Civils de Lyon, Lyon, France. Development and Characterization of Two Polyclonal Antibodies Directed Against Human Periostin. ASBMR 2015

Yu HJ, Tan C, Yan Z, Miller CG, Fuerst T, Engelke K, Metaxas D, BioClinica, Inc., Newtown USA and Germany, Rutgers University, Piscataway USA. Age-related Changes of Thigh Muscle Fat Infiltration in Subjects of the OAI MRI Cohort with and without Radiographic Osteoarthritis. ESCEO 2015.

Klein G, Sampat M, Staewen D, Scott D, Suhy J, BioClinica, Newark, CA, USA. Comparative Assessment of SUVR Methods and Reference Regions in Amyloid PET Studies. AAIC 2015.

Schaerer J, Roche F, Bracoud L, Coste A, Joly C, Oh J, Belaroussi B, Suhy J, BioClinica, Lyon, France and Newark, CA, USA. A jacobian-based method to assess changes in cortical thickness Application to ADNI data and comparison with longitudinal freesurfer. AAIC 2015.

Chassaing E, Vergnaud P, Stoops E, Vanderstichele H and Schubert T, (1) BioClinica LAB, Lyon, France (2) ADx NeuroSciences, Gent, Belgium. Fit-for-Purpose Validation of the Cerebrospinal Fluid Markers Aβ1-40, Aβ1-42 and Total Tau. AAIC 2015.

Yannick Lhoste, Philippe Vergnaud, Emeric Chassaing, Kafui Agbokou, Tanja Schubert, Bioclinica Lab, Lyon, France.  Impact of freezer failure on bone marker stability during serum sample storage.  ECTS 2015

Sampat M, Roche F, Yu P, Schwarz AJ, Schaerer J, Chan G, Belaroussi B, Bracoud L, Suhy J, Oh J, and the Alzheimer's Disease Neuroimaging Initiative 1 BioClinica Newark, CA, USA  and Lyon, France 2 Eli Lilly and Company, Indianapolis, IN, USA. Quantifing neocortical structural changes for clinical trials in alzheimer's disease: Comparison between tensor-based morphometry and longditudinal freesurfer. AAIC 2015.

Pierre Pottecher, Alexander Mühlberg, Oleg Museyko, Valerie Bousson, Klaus Engelke, Jean-Denis Laredo, Hôpital Lariboisière, Paris, France, Inst. of Medical Physics, University of Erlangen-Nuremberg, Germany, BioClinica, Inc., Princeton USA and Germany. Bone and muscle parameters in the prediction of hip fractures from the prospective european femur fracture study (effect). ICFSR 2015.

2014

Yu HJ, Zhang Y, Morges S, Dawson E, Galante N, Belaroussi B, Hoover KB, Miller CG. Reproducibility of a Semi-automatic Knee Joint Analysis Tool. IWOAI, 2014.

L Bracoud, H Schneble, R Gramada, F Bonneville, F Roche, I Guignot, J Schaerer, F Lala, N Sastre, P Ousset, M Pueyo, C Pachai, B Vellas and the Alzheimer's Disease Neuroimaging Initiative BioClinica, Lyon, France, Institut de Recherches Internationales Servier, Suresnes, France C.H.U. Toulouse, France. Longitudinal Volumetric Changes in Controls, MCI and Ad Subjects from the ROSAS Study, as Compared to ADNI2. CTAD, 2014.

Yan Z, Zhang S, Tan C, Zhou Y, Belaroussi B, Yu HJ, Miller C, Metaxas D.  Automatic Liver Segmentation and Hepatic Fat Fraction Assessment in MRI. ICPR, 2014.

Basselerie H, Bracoud L, Schneble HM, Gouttard S, Guignot I, Istace A, Roche F, Schaerer J, Pueyo M, Pachai C, Vellas B, Bonneville F. Microhemorrhage Findings on Baseline Rosas MRI Data. AAIC, 2014.

Istace A, Bracoud L, Berman RM, Luo F, Roche F, Salloway S, van Dyck C, Dubois B, Andreasen N, Brody M, Curtis C, Soininen H, Thein S, Shiovitz T, Ferris S, Grill JD, Gouttard S, Schaerer J, Hayes W, Kaplita S, Belaroussi B, Yu HJ, Cedarbaum JM, Feldman HH, Pachai C, Coric V. Volumetric MRI Results in a Prodromal AD Population. AAIC, 2014.

F. Roche, J. Schaerer, S. Gouttard, A. Istace, B. Belaroussi, HJ. Yu, L. Bracoud, C. Pachai , C. DeCarli and the Alzheimer's Disease Neuroimaging Initiative. Accuracy of BMAS Hippocampus Segmentation Using the Harmonized Hippocampal Protocol. AAIC, 2014.

Yu HJ, Tan C, Yan Z, Belaroussi B, Zhang Y, Metaxas D, Carrino JA, Miller, CG. Tissue Quantification Thigh MRI in Osteoarthritis. IWOAI, 2014.

D Scott, J Suhy, M Sampat, P Chiao, J Sevigny, G Klein 1BioClinica, Newark, CA, USA; 2Biogen Idec, Cambridge, MA, USA. Regionally-specific SUVR values in early-stage AD patients screened with amyloid PET. CTAD, 2014.

Kuo P, Heertum RV, Nguyen B, Bateman D, Symanowski J, Naumann R.  A pilot study assessing interreader variability in the evaluation of folate receptor status of ovarian cancer patients using 99mTc-etarfolatide. J Nucl Med. 2014; 55 (Supplement 1):1435

Yu HJ, Zhang Y, Morges S, Dawson E, Galante N, Belaroussi B, Hoover KB, Miller CG. A Semi-automated Software for Minimal Joint Space Width Detection in Hip Radiographs. IWOAI, 2014.

G Novak, HR Brashear, L Bracoud, E Liu, S Einstein, F Roche, J Schaerer, C Pachai, N Ketter. Rates of Longitudinal Change in Brain Volume in a Clinical Trial of the Anti-Amyloid Vaccine, ACC-001. CTAD, 2014.

Tan C, Yan Z, Zhang S, Belaroussi B, Yu HJ, Miller C, Metaxas D.  A Robust and Automatic Framework for Assessment of the Muscle/Fat Fraction in Thigh. ICPR, 2014.

2013

Bracoud, L., F. Lala, F. Bonneville, M. Pueyo, S. Gouttard, I. Guignot, N. Sastre, P.-J. Ousset, C. Pachai and B. Vellas (2013). The ROSAS study: Baseline MRI characteristics. Alzheimer's & dementia : the journal of the Alzheimer's Association 9(4): P427-P428.

L. Bracoud, K. Marek, J. Cedarbaum, J. Schaerer, S. Mendick, R. Berman, F. Roche, F. Luo, W. Hayes, S. Kaplita, J. Seibyl, C. Pachai, V. Coric and the Alzheimer's Disease Neuroimaging Initiative (2013). Predictive Value of Baseline Hippocampal Volumes and Brain Amyloid Burden on Atrophy Rates for Predementia Alzheimer’s Disease Subjects with Data from Study Cn156-018 and Adni-1.  6th Conference Clinical Trials on Alzheimer’s Disease Abstracts.  November 14–16, 2013 San Diego, CA — USA.

Bracoud, L., S. Gouttard, J. Schaerer, M. Pueyo, F. Bonneville, F. Roche, A. Istace, H.J. Yu, C. Pachai and B. Vellas (2013). Comparison of automated segmentation of intracranial volume between 3D-T1 and 3D-T2 sequences. Alzheimer's & dementia : the journal of the Alzheimer's Association 9(4): P98.

Schaerer, J., B. Singh, F. Roche, B. Belaroussi, E. Fletcher, L. Bracoud, C. Pachai and C. DeCarli (2013). Comparison of manual and automated multi-atlas hippocampal volume measurements in the University of California, Davis, Alzheimer's Disease Center cohort. Alzheimer's & dementia : the journal of the Alzheimer's Association 9(4): P97-P98.

Miller C.G., Yu H.J., Horvath B., Libber J., Krueger D., Binkley N. (2013) Using Body Composition Phantoms to Validate Performance of Dual Energy X-Ray Absorptiometry (DXA) Instrument. J Bone Miner Res 28 (Suppl 1).

Roche, F., B. Singh, J. Schaerer, B. Belaroussi, S. Gouttard, A. Istace, H. J. Yu, E. Fletcher, L. Bracoud, C. Pachai and C. DeCarli (2013). Reproducibility of intracranial and hippocampal volume quantification at 1.5T and 3T MRI: Application to ADNI I. Alzheimer's & dementia : the journal of the Alzheimer's Association 9(4): P271.

L. Bracoud, R. Berman, F. Roche, V. Coric, S. Gouttard, F. Luo, J. Schaerer, W. Hayes, A. Istace, S. Kaplita, B. Belaroussi, H.J. Yu, C. Pachai, J.

Margolin, R., N. Ketter, S. Guthrie, D. Deegan, L. Baher, R. Tschopp, K. Marek, J. Seibyl, G. Novak, J. Streffer, C. Pachai, B. Wyman, K. Booth, E. Yuen, D. Gennevois and E. Liu (2013). Biomarker strategy for enrichment and monitoring of biological effect in ACCTION, a phase II study of ACC-001 (vanutide cridificar) for Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association 9(4): P289-P290.

A. Istace, V. Coric, F. Roche, S. Kaplita, J. Schaerer, F. Luo, S. Gouttard, J. Cedarbaum, L. Bracoud, W. Hayes, B. Belaroussi, H.J. Yu, C. Pachai, R. Berman (2013).  Comparison of Boundary Shift Integral and Tensor Based Morphometry to Assess Volume Changes on Whole Brain and Lateral Ventricles – Application To Study Cn156-018. 6th Conference Clinical Trials on Alzheimer’s Disease Abstracts November 14–16, 2013 San Diego, CA — USA.

Gouttard, S., J. Schaerer, H.J. Yu, A. Istace, F. Roche, C. Pachai and L. Bracoud (2013). Impact of parallel imaging on volumetric brain MRI measurements in ADNI-GO and ADNI-2. Alzheimer's & dementia : the journal of the Alzheimer's Association 9(4): P100-P101.

J. Schaerer, F. Luo, S. Gouttard, J. Cedarbaum, L. Bracoud, V. Coric, F. Roche, S. Kaplita, A. Istace, W. Hayes, H.J. Yu, C. Pachai, R. Berman (2013).  Comparison of Intracranial Volume Quantification Based on 2D T2* and 3D T1-Weighted MRI Sequences.  6th Conference Clinical Trials on Alzheimer’s Disease Abstracts November 14–16, 2013 San Diego, CA — USA. The Journal of Nutrition, Health & Aging 17(9): 774-856.

2012

Yu HJ, Belaroussi B, Bracoud L, Guthrie S, Einstein S, DeCarli S, Novak G, Pachai C. Impact of Hippocampal Volume–Based Enrichment on Clinical Outcomes in Prodromal AD Trials Up to 3-Years Follow-Up. AAIC 2012, Vancouver, Canada.

R. McCarrie, C.G. Miller, Ph.D. X-Ray Acquisition Challenges in Clinical Trials: Challenges and Solutions Posed by the Synaflexer. OA Biomakers Global Initiative 2012, Hilton Head Island, South Carolina.

V Navarro-Compán, R Landewé, H Ahmad, C Miller, D Xu, D van der Heijde. Prediction of rate of adjucication of radiological progression in rheumatoid arthritis (RA) randomized controlled trials (RCTs) in early and established disease. Annual European Congress of Rheumatology EULAR 2012, London, United Kingdom.

Novak G, Yu HJ, Einstein S, Guthrie S, Margolin R, Bracoud L, Belaroussi B, DeCarli S, Pachai C. Choice of Threshold Hippocampal Volume as a Selection Criterion in Prodromal Alzheimer’s Disease. AAIC 2012, Vancouver, Canada.

L. Bracoud, B. Belaroussi, K. Lobello, D. Li, HJ. Yu, C. Pachai, B. Wyman. Correlation between DWI-ADC and clinical scores in mild to moderate Alzheimer’s disease. AAIC 2012, Vancouver, Canada.

J.Schaerer, L.Bracoud, F.Roche, HJ.Yu, B.Belaroussi, D.Xu, C.Pachai, C.DeCarli and the Alzheimer’s Disease Neuroimaging Initiative.  Validation of a multi-atlas segmentation technique for the quantification of hippocampal volume – Application to ADNI I. CTAD 2012, Monte Carlo.

V Navarro-Compán, D van der Heijde, H Ahmad, C Miller, R Landewé. Calculation of the smallest detectable change (SDC) of radiographic progression in clinical trials with multiple time points: the mean SDC is a valid approximation of the overall SDC. Annual European Congress of Rheumatology EULAR 2012, London, United Kingdom.

Novak G, Einstein S, Guthrie S, Margolin R, Yu HJ, Bracoud L, Belaroussi B, DeCarli S, Pachai C. Discordance for Hippocampal Atrophy and Amyloid Burden in Amnestic Mild Cognitive Impairment May Identify Distinct Subgroups of Patients. AAIC 2012, Vancouver, Canada.

HJ.Yu, L.Bracoud, J.Schaerer, D.Xu, F.Roche, B.Belaroussi, C.Pachai, C.DeCarli and the Alzheimer’s Disease Neuroimaging Initiative. Validation of a multi-atlas segmentation technique for the quantification of hippocampal volume - Application as a selection criterion in clinical trials in Alzheimer’s Disease. CTAD 2012, Monte Carlo.

J. Schaerer, B. Belaroussi, F. Roche, F. Bonnand, HJ. Yu, C. Pachai and the Alzheimer's Disease Neuroimaging Initiative. Accurate Intracranial cavity volume estimation in Mild Cognitively Impaired population using multi- atlas segmentation. AAIC 2012, Vancouver, Canada.

E DeYoe, PhD, J Voyvodic, PhD, C Elsinger, PhD (co-chair), J Petrella, MD (co-chair), H Ahmad, MD, A Buckler, MS, F Mohamed, PhD, J Pillai, MD, J Reuss, PhD, D Zaca, PhD representing The RSNA QIBA-fMRI Committee. Reproducibility of Functional MRI – Progress Towards Profile Development. ASFNR 2012, Orlando, Florida.

B. Belaroussi, F. Roche, J. Schaerer, L. Bracoud, HJ. Yu, C. Pachai and the Alzheimer's Disease Neuroimaging Initiative. Multi-atlas segmentation of the hippocampus refined with intensity-based tissue classification. AAIC 2012, Vancouver, Canada.

L. Bracoud, V. Coric, C.H. van Dyck, N. Andreasen, J. Ross, M. Brody, C. Curtis, B. Belaroussi, HJ. Yu, S. Kaplita, H. Feldman, C. Pachai and R.M. Berman. Baseline clinical scores and volumetric MRI parameters across subjects randomized in mild-to-moderate (BMS CN156-013) and predementia (BMS CN156-018) Alzheimer’s disease clinical trials of avagacestat. AAIC 2012, Vancouver, Canada.

C.G. Miller, Ph.D., B. Horvath, H.J. Yu, Ph.D., S. Jackson, MD, N. Binkley, MD. Dual Energy X-Ray Absorptiometry Body Composition: A New Phantom for Clinical Trials. ASBMR Topical Meeting on Bone and Skeletal Muscle Interactions 2012. Kansas City , Missouri.

L. Bracoud, H. Ahmad, A. Lopez, E. Brill Almon and R. Chertkoff. Variability assessment of spleen volume measurements based on MRI sequence selection in Gaucher subjects. EWGGD 2012, Paris, France.

2011

Belaroussi, B., L. Bracoud, et al. (2011). High-throughput and accurate segmentation of lateral ventricles and other structures using combined single atlas propagation and tissue classification: Application to ADNI and IBSR data. International Congress on Alzheimer’s Disease, Paris, France.

Bracoud, L., A. Caputo, et al. (2011). Longitudinal ADC changes in Alzheimer’s Disease in a multi-center clinical trial setting. International Congress on Alzheimer’s Disease, Paris, France.

Belaroussi, B., L. Bracoud, et al. (2011). Whole-Brain and ventricular volume change measurement in multicenter clinical trials: A feasibility study of Jacobian Integration using ADNI data. International Congress on Alzheimer’s Disease, Paris, France.

E DeYoe, J Voyvodic, CElsinger, J Petrella, H Ahmad, A Buckler, F Mohamed, J Pillai, J Reuss, D Zaca. Reproducibility of Functional MRI – Progress Towards Profile Development (QIBA Presentation at RSNA 2011)

Belaroussi, B., F. Durand-Dubief, et al. (2011). FreeSurfer Reproducibility of MRI-derived measurements of longitudinal volume changes in MS subjects: Impact of change in MRI scanners. ECTRIMS, Amsterdam, The Netherlands.

Ahmad, H., C. G. Miller, et al. (2011). Blinded Reads in Rheumatoid Arthritis Clinical Trials: Adjudication Rates for Varying Thresholds Based on Change Scores of Two Readers Utilizing X-Rays of the Hands and Feet. Annual European Congress of Rheumatology EULAR 2011, London, United Kingdom.

2010

Elsinger C, Petrella J, Ahmad H, Barboriak D, Buchbinder B, Buckler A, Clarke G, DeYoe E, Faro S, Gupta S, Jackson E, Mohamed F, Mukundan S, Pillai J, Reuss J, Sullivan D, Tucker D, Voyvodic J, Zaca D, Zahlmann G, Advancing BOLD Functional MR Imaging Technology – Roadmap for Developing a Quantitative Imaging Biomarker Poster Presentation at RSNA 2010

L. Bracoud, H. Ahmad, E. Brill Almon and R. Chertkoff. Measurement of spleen and liver volumes using MRI in an enzyme-replacement therapy multi-center trial on naïve patients with Gaucher Disease. European Working Group on Gaucher disease (EWGGD) 2010.

2009

Saver JL, Albers GW, Dunn B, Johnston KC, Fisher M; STAIR VI Consortium (contributor Ahmad H). Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials. Stroke. 2009 Jul;40(7):2594-600.

2008

B. Belaroussi, L. Bracoud, F. Bonnand, F. Vincent, K. Noever and C. Pachai. Brain Atrophy Measurement in Multicenter studies: Application of Brain Boundary Shift Integral and Jacobian Integration International Conference on Alzheimer’s Disease. 24-27 June 2008, Chicago, USA.

2007

T Fuerst, T Beck. K Gaither, M Kothari, H Genant: Oral lbandronate Improves Hip Structural Parameters in the BONE Study. ECTS 2007.

2006

T Fuerst, TJ Beck, K Gaither, M Kothari, HK Genant: Effect of Oral lbandronate on Hip Structure: Results from the BONE Study. J Bone Miner Res 21:S287, 2006.

K Faulkner, J Shepherd, K Gaither, B Fan, E Lewiecki, PD Miller, HK Genant: Disagreement in Hip Strength Analysis Results between GE Lunar and Hologic DXA Systems. J Bone Min Res 21 :S286, 2006.

2004

Faro SH, Haddonfield NJ, Mohamed F, Gordon N, Platek S, Williams M, Ahmad H. Functional MRI of Deception and Truth with Polygraph Correlation. Radiology Society of North America (RSNA) Abstract Proceedings. 2004;p282.

2003

Mohamed FB, Gordon NJ, Pinus A, Ahmad H, Williams M, Tracy JI, Faro SH. fMRI Study of Truth & Deception Using Classical Question Technique 11th Scientific Meeting of the International Society of Magnetic Resonance in Medicine. 2003 p. 1920

Mohamed FB, Khaled KA, Faro SH, Pinus A, Ahmad H, Williams M, Haselgrove J, Assaf B. Hippocampal Diffusion Tensor Measurements in Temporal Lobe Epilepsy 11th Scientific Meeting of the International Society of Magnetic Resonance in Medicine. 2003. p. 2227

2001

Alters S, Perrone A, Cheal K, Cromer R, Snapper J, Kantor A.  Phenotypic profiling in allergy and asthma: effects of glucocorticosteriods on cell surface and soluble factors.  Federation of Clinical Immunolgy Societies. 2001.

Alters S, Perrone A, Cheal K, Cromer R, Snapper J, Kantor A.   Phenotypic profiling in allergy aand asthma: effects of glucocorticosteriods on cell surface and soluble factors.  European Asthma Congress. 2001.

Alters S, Perrone A, Cheal K, Cromer R, Snapper J, Kantor A. Identification of biomarkers in allergy and asthma: effects of glucocorticosteriods on cell surface and soluble factors.  American Academy of Allergy, Asthma and Immunology abstract. 2001.

2000

Pierre H, Lacroix Z, Perrone A.  Longitudinal Patient-Centered Collection and Analysis of Clinical Data.  Proceedings. IEEE EMBS 3rd International Conference Information Technology Applications in Biomedicine. Arlington, VA. 2000, p. 316-23.

K Gaither, M Tran, E Griffith, L Vilstrup, E Paris, P Steinbach: Retrieval of DXA data archived after closure of a clinical trial. Program, Sixth Annual Meeting of the International Society of Clinical Densitometry, May 2000.

1999

Mehta MP, Eisenberg P, Schultz CJ, et. al. Computer Assisted Masked MRI Analysis of Volumetric Response: Implementation for A Phase III Protocol of Gadolinium Texpaphyrin (Gd-Tex) in Patients with Brain Metastases. Society of Neuro-Oncology Annual Meeting, 1999 October.

Mehta MP, Eisenberg P, Schultz CJ, et. al. Computer Assisted Masked MRI Reading in a Phase III Trial of Gadolinium Texpaphyrin (Gd-Tex) in Patients with Brain Metastases. Society of Neuro-Oncology Annual Meeting. 1999.

1998

Rosen C, McClung M, Gallagher C, Baldwin D, Faulkner K, Trempe J, Miller C. Heel ultrasound reference data for caucasian women in the USA. Journal of Clinical Densitometry. 1998; 1(1):107.

K Gaither, L Roberts, K Faulkner and P Miller: National Osteoporosis Risk Assessment, Quality Control and Quality Assurance. Program, Fourth Annual Meeting of the International Society of Clinical Densitometry, January 1998.

G Fasano, K Gaither, E Siris, P Miller, E Sarrett-Connor, M Berger, L Sherwood, A Santora, K Faulkner: The Impact of Quality Assurance on Bone Densitometry in the National Osteoporosis Risk Assessment. J Bone Min Res 11(suppi 1):

1996

Gaither KW, Faulkner KG, Ostrem EC, Backman JK, Avecilla JS, McClung MR: Variations in calibration among like-manufacturer DXA systems. J Bone Min Res 11(supple 1):100.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

What's next from Bioclinica? Hear if first during #PCTrials Europe next week in Amsterdam! https://t.co/ICngaxA9mg https://t.co/SXxPj3NpD2
bioclinica (5 hours ago)
Join Bioclinica's Justin Hunt on Nov. 28 in a live webinar! Find out how to overcome common hurdles in CTMS impleme… https://t.co/wHfWHtI7sj
bioclinica (Yesterday)
Another CRO seeing big gains in the sites payments process! Access the Case Study here https://t.co/jsCxhmKcLo https://t.co/LpIKEtBKtE
bioclinica (Yesterday)
Great advice from our Dir. Cardiovascular Imaging on quality imaging acquisitions & assessments in clin trials. https://t.co/OVH7pZ3SL0
bioclinica (Yesterday)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will give a… https://t.co/8ymd2Q9KcJ
bioclinica (Yesterday)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will giv… https://t.co/MpxTDV1T1L
bioclinica (Yesterday)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices